Image default
Water News

Covid 19 Vaccine: Wockhardt in discussions with vaccine developers to offer drug substance


Drug firmWockhardton Tuesday said it is in discussions with a number of global COVID-19vaccinedevelopers to offerdrug substanceas well as fill and finishmanufacturing facilitiesto them.

According to the company, the UK government has reserved one fill and finish production line at Wockhardt UK for its exclusive use for 18 months in order to guarantee the supply of vaccines required to fight against COVID-19.

“We are in discussions with a number of vaccine developers worldwide offering both drug substance, and fill and finish manufacturing, because most of the companies want drug substance as well as formulation product,” Wockhardt Chairman Habil Khorakiwala said during a virtual media conference.

Wockhardt is offering such options as a contract manufacturing organisation activity or as distribution rights, depending on what they want, he added.

(Catch all theBusiness News,Breaking NewsEvents andLatest NewsUpdates onThe Economic Times.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

Source

Related posts

Autopsy finds Covid-19 patient’s lungs ‘hard as a leather ball’

TheEarthLab

Rhizen Pharmaceuticals gets USFDA approval for phase one clinical trials for Covid-19 drug

TheEarthLab

Chemotherapy drug more effective when combined with microbubbles

TheEarthLab

Leave a Comment